Clinical Trial Update: The Rilpivirine Cerebrospinal-fluid (CSF) Study [Phase 1]

View source ↗

Summary

Phase 1 study assessing rilpivirine concentrations in cerebrospinal fluid in HIV-infected participants. The study is completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• rilpivirine (rilpivirine)

Snippet

Sponsor: Imperial College London | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2014-06-19